Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Guangzheng Group

A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline

  • Post date May 8, 2022 — 21:55 Post Lock Login to View

Read More

A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D

  • Post date May 8, 2022 — 20:56 Post Lock Login to View

Read More

UCED (688158): UCID Technology Co., Ltd. on the re-appointment of the accounting firm in 2022- CFi.CN Zhongcai Network

  • Post date April 26, 2022 — 22:57 Post Lock Login to View

Read More

[Express] Industrial Welfare Bonds Announces First Quarterly Report CFi.CN

  • Post date April 22, 2022 — 15:56 Post Lock Login to View

Read More

List of pre-loss companies in the first quarter_ Oriental Fortune Net

  • Post date April 22, 2022 — 10:26 Post Lock Login to View

Read More

Guangzheng Ophthalmology: Zhu Xingyu, Secretary of the Board of Directors of the Company, Resigns_ Oriental Fortune Net

  • Post date April 18, 2022 — 18:30 Post Lock Login to View

Read More

Guangzheng Ophthalmology Board Secretary Zhu Xingyu resigns

  • Post date April 18, 2022 — 18:30 Post Lock Login to View

Read More

Guangzheng Ophthalmology (002524.SZ) Board Secretary Zhu Xingyu resigns

  • Post date April 18, 2022 — 18:25 Post Lock Login to View

Read More

List of pre-loss companies in the first quarter_ Oriental Fortune Net

  • Post date April 15, 2022 — 09:12 Post Lock Login to View

Read More

Aide Bio (300685): It is proposed to appoint the company's 2022 annual audit agency-

  • Post date April 11, 2022 — 21:03 Post Lock Login to View

Read More

Guangzheng Ophthalmology: It plans to sell part of the equity of Xintianshan, a wholly-owned subsidiary, and sign the "Letter of Intent for Equity Transfer" _ Oriental Fortune Net

  • Post date April 11, 2022 — 20:16 Post Lock Login to View

Read More

Guangzheng Ophthalmology (002524.SZ) plans to sell 10% equity of Xintianshan to promote the company's transformation and upgrading

  • Post date April 11, 2022 — 20:16 Post Lock Login to View

Read More

Guangzheng Ophthalmology (002524.SZ) plans to sell 10% equity of Xintianshan to promote the company's transformation and upgrading

  • Post date April 11, 2022 — 20:15 Post Lock Login to View

Read More

Guangzheng Ophthalmology plans to sell 10% equity of Xintianshan to promote the company's transformation and upgrading

  • Post date April 11, 2022 — 20:15 Post Lock Login to View

Read More

Focus on the main business Guangzheng Ophthalmology plans to sell part of the equity of Xintianshan

  • Post date April 11, 2022 — 20:11 Post Lock Login to View

Read More

Guangzheng Ophthalmology (002524.SZ) plans to sell 10% equity of Xintianshan to promote the company's transformation and upgrading_Individual Stock Information_Market Gold Online

  • Post date April 11, 2022 — 20:11 Post Lock Login to View

Read More

Focusing on the main business Guangzheng Ophthalmology to sell part of the equity of Xintianshan

  • Post date April 11, 2022 — 20:10 Post Lock Login to View

Read More

  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.